Transparency · openFDA

Complete response letters

FDA's letters telling drug and biologic applicants why an application was not approved as submitted. 458 records; openFDA updated it 2026-11-10. About this dataset

Newest records

Later approved?
  • Approved309
  • Unapproved149
  • Ferring Pharmaceuticals Inc. · BLA 761253

    PrN U.S. FOOD & DRUG ADMINISTRATION BLA 761253 COMPLETE RESPONSE Ferring Pharmaceuticals Inc. Attention: Sangeeta Chavan Patil Director, Regulatory Affairs 100 Interpace Parkway Parsippany, NJ 07054…

    COMPLETE RESPONSEUnapproved
  • Amphastar Pharmaceuticals, Inc. · BLA 761403

    PN U.S. FOOD & DRUG ADMINISTRATION BLA 761403 COMPLETE RESPONSE Amphastar Pharmaceuticals, Inc. Attention: Magda Albedrop, RAC-Drugs Senior Supervisor of the CMC and Submissions Group Regulatory Affa…

    COMPLETE RESPONSEUnapproved
  • Achieve Life Sciences, Inc. · NDA 218995

    ADMINISTRATION i Lk YN U.S. FOOD & DRUG NDA 218995 COMPLETE RESPONSE Achieve Life Sciences, Inc. 22722 29th Dr. SE, Suite 100 Bothell, WA 98021 Attention: | Sarah Telzrow Vice President, Regulatory A…

    COMPLETE RESPONSEUnapproved
  • Evergreen Theragnostics, Inc. · NDA 216900

    PN U.S. FOOD & DRUG ADMINISTRATION NDA 216900 COMPLETE RESPONSE Evergreen Theragnostics, Inc. C/o Bourque Regulatory CMC, Inc. Attention: Mr. Jeffrey Bourque President, Bourque Regulatory CMC, Inc. 2…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research,Food and Drug Administration
  • Tris Pharma, Inc. · NDA 220138

    i Lk YN U.S. FOOD & DRUG ADMINISTRATION NDA 220138 COMPLETE RESPONSE Tris Pharma, Inc. Attention: Rashmi Aravind Senior Director of Regulatory Affairs 2033 Route 130 Suite #D Monmouth Junction, NJ 08…

    COMPLETE RESPONSEUnapproved
  • Grace Therapeutics U.S., Inc. · NDA 220304

    g U.S. FOOD & DRUG Naty ADMINISTRATION NDA 220304 COMPLETE RESPONSE Grace Therapeutics U.S., Inc. Attention: Amresh Kumar Vice President of Program Management 103 Carnegie Center Drive, Suite 300 Pri…

    COMPLETE RESPONSEUnapproved
  • AbbVie Inc. · BLA 761459

    nN U.S. FOOD & DRUG ADMINISTRATION BLA 761459 COMPLETE RESPONSE AbbVie Inc. Attention: Felipe Martins Associate Director, Regulatory Affairs 2525 Dupont Drive Irvine, CA 92612 Dear Felipe Martins: Pl…

    COMPLETE RESPONSEUnapproved
  • Ocuvex Therapeutics, Inc. · NDA 217363

    yy U.S. FOOD & DRUG ADMINISTRATION NDA 217363 COMPLETE RESPONSE Ocuvex Therapeutics, Inc. Attention: Anthony Amato Chief Executive Officer 1 Bridge Plaza, Second Floor Fort Lee, NJ 07024 Dear Anthony…

    COMPLETE RESPONSEUnapproved
  • Tanvex BioPharma USA, Inc. · BLA 761266

    i Lk YN U.S. FOOD & DRUG ADMINISTRATION BLA 761266 COMPLETE RESPONSE Tanvex BioPharma USA, Inc. Attention: Bonnie J. Mills, PhD 10394 Pacific Center Court San Diego, CA 92121 Dear Dr. Mills: Please r…

    COMPLETE RESPONSEUnapproved
  • Swedish Orphan Biovitrum AB (publ) · BLA 761438

    g U.S. FOOD & DRUG x ADMINISTRATION BLA 761438 COMPLETE RESPONSE Swedish Orphan Biovitrum AB (publ) Attention: Bao Le US Regulatory Lead, Immunology 77 4th Avenue, 3 Floor Waltham, MA 02451 Dear Bao…

    COMPLETE RESPONSEUnapproved
  • ITM Solucin GmbH · NDA 218705

    g U.S. FOOD & DRUG Naty ADMINISTRATION NDA 218705 COMPLETE RESPONSE ITM Solucin GmbH c/o Lumara Bio USA Inc. Attention: Tinya Sow, MHA US Agent, Director - US, Regulatory Lead 5 Vaughn Drive, Suite 3…

    COMPLETE RESPONSEUnapproved
  • Cingulate Therapeutics, LLC · NDA 220283

    g U.S. FOOD & DRUG Naty ADMINISTRATION NDA 220283 COMPLETE RESPONSE Cingulate Therapeutics, LLC Attention: Kelly R. Koehn Vice President, Clinical and Regulatory Operations 1901 W. 47" Place Westwood…

    COMPLETE RESPONSEUnapproved
  • NeuroDerm, Ltd. · NDA 218317

    ADMINISTRATION f ¢ yy U.S. FOOD & DRUG NDA 218317 COMPLETE RESPONSE NeuroDerm, Ltd. c/o: The ProPharma Group Attention: Daniel Solorio Senior Vice President, Regulatory Program Management 1129 20th S…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • Seikagaku Corporation · BLA 761393

    IN U.S. FOOD & DRUG ADMINISTRATION Net BLA 761393 COMPLETE RESPONSE Seikagaku Corporation c/o PAREXEL International 2520 Meridian Parkway, Suite 100 Durham, NC 27713 Attention: Katherine Fertal US Ag…

    COMPLETE RESPONSEUnapproved
  • Immedica Pharma AB · BLA 761211

    IN U.S. FOOD & DRUG Se ADMINISTRATION BLA 761211 COMPLETE RESPONSE Immedica Pharma AB % DLRC Inc. Attention: Gregory Dombal President 1 Broadway Cambridge, MA 02142 Dear Gregory Dombal: Please refer…

    COMPLETE RESPONSEUnapprovedCenter tor Drug Evaluation and Research
  • Tanvex BioPharma USA, Inc. · BLA 761266

    ADMINISTRATION i Lk YN U.S. FOOD & DRUG BLA 761266 COMPLETE RESPONSE Tanvex BioPharma USA, Inc. Attention: Bonnie Mills, PhD Regulatory Consultant 2030 Main Street, Suite 600 Irvine, CA 92614 Dear Dr…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • Milestone Pharmaceuticals USA, Inc. · NDA 218571

    IN U.S. FOOD & DRUG ADMINISTRATION Net NDA 218571 COMPLETE RESPONSE Milestone Pharmaceuticals USA, Inc. Attention: Joseph Oliveto CEO 6210 Ardrey Kell Rd., Suite 650 Charlotte, NC 28277 Dear Joseph O…

    COMPLETE RESPONSEUnapprovedCenter for Drug Evaluation and Research
  • Alvotech USA Inc. · BLA 761435

    Lk U.S. FOOD & DRUG “a ADMINISTRATION BLA 761435 COMPLETE RESPONSE Alvotech USA Inc. c/o Cencora Global Consulting Service Attention: Anusha Kesireddy Manager, Regulatory Affairs 1 West 1st Avenue Co…

    COMPLETE RESPONSEUnapproved
  • Conjupro Biotherapeutics Inc. · NDA 218923

    YN U.S. FOOD & DRUG ADMINISTRATION NDA 218923 COMPLETE RESPONSE Conjupro Biotherapeutics Inc. Attention: Xi-De Wang, Ph.D., RAC Vice President, Regulatory Science & Compliance 302 Carnegie Center, Su…

    COMPLETE RESPONSEUnapproved
  • SFJ Pharmaceuticals, Inc. · BLA 761290

    a g PN U.S. FOOD & DRUG ADMINISTRATION BLA 761290 COMPLETE RESPONSE SFJ Pharmaceuticals, Inc. Attention: Michele LaRussa SVP, Chief Regulatory Officer 109 Grey Bridge Row Cary, NC 27513 Dear Michele…

    COMPLETE RESPONSEUnapproved
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.